We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Kendro Acquires H+P Labortechnik

By HospiMedica staff writers
Posted on 20 Apr 2004
In a move that will add new product lines to the company's portfolio, Kendro Laboratory Products, a business of SPX Corp. (Charlotte, NC, USA), has acquired H+P Labortechnik AG (Oberschleissheim, Germany). Terms were not disclosed.

With annual revenues in excess of U.S.$12 million, H+P provides a wide range of Varioklav steam sterilizers and Variomag magnetic stirrers for the pharmaceutical, biotech, academic, and medical markets. Kendro designs, manufactures, and markets a wide range of equipment for sample storage, preparation, and processing. SPX is a global provider of technical products and systems, industrial products, and service solutions.

"The addition of H+P strengthens our technology base and adds several new product lines to our current product and service offering,” said Dennis M. Pope, president of Dendro. "H+P's premier product position and high-quality image complement the Kendro brands and enhance our ability to provide customers with complete solutions through our existing worldwide sales channels.”




Related Links:
SPX Corp.
H+P

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
20 Apr 2004  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
20 Apr 2004  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
20 Apr 2004  |   Industry